Significance of whole-process individualized bowel management in radiotherapy for gynecologic tumors: a prospective, randomized, controlled clinical study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059564

Enrollment

Unknown

Registered

2022-05-04

Start date

2022-05-09

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecologic tumors

Interventions

Experimental group:whole-process individualized bowel management

Control group:none

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Gynecological tumor radiotherapy patients; 2. Aged 18 to 70 years; 3. Physical condition (KPS) score >=70; 4. With complete electrocardiogram, blood routine, liver and kidney function tests, excluding those contraindicated by radiotherapy; 5. Consent and ability to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have previously received pelvic radiotherapy; 2. History of colorectal surgery; 3. Severe intestinal stenosis or obstruction; 4. Have participated in other relevant studies; 5. Patients who cannot communicate.

Design outcomes

Primary

Measure	Time frame
The rectum diameter;Targeting efficiency;	—

Secondary

Measure	Time frame
Quality of life;Anxiety-depression;Setup errors;Fatigue status;Rectal dose;Toxicity;	—

Countries

China

Contacts

Public ContactBai Fei

The First Affiliated Hospital of Air Force Military Medical University

baifei0912@163.com+86 13488149902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026